Nanochon Secures Panamá Health Ministry Approval to Begin First-in-Human Chondrograft™ Clinical Study Radiation Detection Company (RDC), a long-established provider of occupational radiation dosimetry services, has announced the launch of Radiant,…
Radiation Detection Company Launches Radiant Real-Time Dosimetry Solution to Enhance Radiation Safety in Medical Settings Radiation Detection Company (RDC), a long-established provider of occupational radiation dosimetry services, has announced the…
FDA Approves LEROCHOL Autoinjector for Once-Monthly Self-Administration in Patients With High Cholesterol LIB Therapeutics, Inc. (LIB), a privately held biopharmaceutical company focused on helping high-risk patients achieve and maintain recommended…
Sinovac Reports 12.9% Revenue Growth in First Half of 2026 as Overseas Vaccine Business Expands Sinovac Biotech Ltd., a leading biopharmaceutical company in China, has announced the filing of its…
Canopy Growth Distributes 2026 Annual Meeting Materials and Urges Shareholders to Vote Ahead of September 25 Meeting Canopy Growth Corporation, a global company focused on the cannabis sector, has announced…
Zai Lab and argenx Report Positive Phase 3 Results for VYVGART Hytrulo in Autoimmune Myositis Zai Lab Limited and argenx have announced positive topline results from the ALKIVIA Phase 3…
Life Couriers Completes Acquisition by JLL Partners and Appoints Edward DeMartini as CEO to Drive Global Healthcare Logistics Growth Life Couriers, a global provider of time-critical healthcare logistics and transportation…
Enhertu Demonstrates Significant Progression-Free Survival Benefit in First-Line HER2 Mutant Metastatic NSCLC Daiichi Sankyo and AstraZeneca have announced positive topline results from the Phase 3 DESTINY-Lung04 trial, demonstrating that Enhertu®…
EMA Validates Pfizer and Valneva’s Marketing Authorization Application for Lyme Disease Vaccine Candidate Pfizer Inc.and Valneva SE have announced an important regulatory milestone for their investigational Lyme disease vaccine candidate,…
U.S. FDA Grants Accelerated Approval to Bristol Myers Squibb’s ZENBEXUS™ in Combination Therapy for Multiple Myeloma at First Relapse Bristol Myers Squibb has announced that the U.S. Food and Drug…
Gossamer Bio Reports Second-Quarter 2026 Results and Advances Seralutinib Toward Planned FDA Submission Gossamer Bio, Inc., a clinical-stage biopharmaceutical company focused on developing and potentially commercializing therapies for pulmonary vascular…
AIVITA Biomedical Named 2026 Prix Galien USA “Best Startup” Nominee for Personalized Immunotherapy Innovation AIVITA Biomedical, Inc., a biotechnology company developing personalized vaccines and immunotherapies for infectious diseases and cancer,…